MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial. The new data ...

MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

So, you like games? Vulture’s Movies Fantasy League just kicked off its new season. It’s fun, it’s free, and there are some killer prizes on the line. Sign up to play here, or learn more at the MFL ...

After starting my career at PCMag as an intern more than a decade ago, I’m back as one of its editors, focused on managing laptops, desktops, and components coverage. With 15 years of experience, I ...

An organization is hosting camp focusing on uplifting and empowering girls and young women up in Prescott this weekend, and that is Something Good. One of the Valley’s top Halloween attractions has ...

Tilt Renewables has appointed Philip Bainbridge as the new Independent chairman of the board, following the retirement of longtime Chairman, Cheryl Bart. The AEMC says it has reappointed Rachele ...